Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;11(7):1175-1181.
doi: 10.1016/j.jgo.2020.05.001. Epub 2020 May 10.

Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective

Affiliations
Review

Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective

Isacco Desideri et al. J Geriatr Oncol. 2020 Sep.

Abstract

The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions of people in over 180 territories, causing a significant impact on healthcare systems globally. Older adults, as well as people living with cancer, appear to be particularly vulnerable to COVID-19 related morbidity and mortality, which means that older adults with cancer are an especially high-risk population. This has led to significant changes in the way geriatric oncologists provide care to older patients, including the implementation of novel methods for clinical visits, interruptions or delays in procedures, and modification of therapeutic strategies, both in the curative and palliative settings. In this manuscript, we provide a global overview of the perspectives of geriatric oncology providers from countries across Europe, America, and Asia, regarding the adaptive strategies utilized to continue providing high quality care for older patients with cancer during the COVID-19 pandemic. Through these perspectives, we attempt to show that, although each country and setting has specific issues, we all face similar challenges when providing care for our older patients with cancer during these difficult times.

Keywords: COVID-19; Delivery of healthcare; Global health; Older adults; Pandemics.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr. Battisti has received travel grants and speaker fees from Pfizer and travel grants from Genomic Health. Dr. Loh serves as a consultant to Pfizer and Seattle Genetics. Dr. Loh is supported by the Wilmot Research Fellowship Award and National Cancer Institute (K99CA237744). Dr. Neuendorff has received honoraria and travel support by Janssen-Cilag, Medac, and Jazz Pharmazeutical. Dr. Mian reports Honoraria/Consultancy fees from Amgen, Celgene, Takeda, Janssen, Sanofi. All other authors have no financial conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
COVID-19 data, including incidence, mortality, and government response, for selected countries and territories in Europe (A), North America (B) and Asia (C). Data current as of April 19, 2020, 1:00 PM GMT-5:00. Obtained from the Johns Hopkins University Coronavirus Resource Center at https://coronavirus.jhu.edu/map.html [34].
Fig. 2
Fig. 2
Estimated worldwide age-standardized incidence rates for the year 2018, all cancers, both sexes, aged ≥65 [4].

References

    1. WHO . 2020. COVID-19 Dashboard. https://covid19.who.int/ [accessed 22 April 2020]
    1. Liang W., Guan W., Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. - PMC - PubMed
    1. Burki T.K. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020;21:629–630. - PMC - PubMed
    1. Ferlay J., Ervik M., Lam F. 2018. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today. [accessed 22 April 2020]
    1. Arnold M., Rutherford M.J., Bardot A. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20:1493–1505. - PMC - PubMed

Publication types

MeSH terms